A Phase 4 Observational, Real-World Study of 20-valent Pneumococcal Conjugate Vaccine Effectiveness Against Vaccine-Type Invasive Pneumococcal Disease in Adults Aged 65 years and above

27/03/2024
04/05/2026
EU PAS number:
EUPAS1000000007
Study
Ongoing
Subscribe
Download as PDF
Documents
Study protocol
Updated protocol

Pfizer_Adult_PCV20_EMA Study protocol_V3.0_03Feb2026.pdf

First published: 28/04/2026
English (1.38 MB - PDF) View document

Pfizer_PCV20_EMA Study protocol_v1.1_02JUL2024_clean (1).pdf

First published: 18/10/2024
English (1.26 MB - PDF) View document
Study results
Study report
Other information